This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman, provides a succinct state of the psychedelics industry before focusing on unanswered questions across psychedelic drug development, clinical rollout, and policy, including…

Source

Previous articleFebruary 2026 Psychedelic Bill Round-up
Next articlePsilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials